Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5127]
News [14850]
Articles [105]
Editorials [3]
Conferences [245]
elearning [21]
SABCS 2023: Exercise may boost quality of life for patients with metastatic breast cancer
SABCS 2023: Exercise may boost quality of life for patients with metastatic breast cancer
FDA grants accelerated approval to pirtobrutinib for chronic lymphocytic leukaemia and small lymphocytic lymphoma
FDA grants accelerated approval to pirtobrutinib for chronic lymphocytic leukaemia and small lymphocytic lymphoma
SABCS 2023: Potentially targetable fusion RNAs may be more common in metastatic breast cancer than previously realised
SABCS 2023: Potentially targetable fusion RNAs may be more common in metastatic breast cancer than previously...
SABCS 2023: Skipping adjuvant radiotherapy may not impact risk of recurrence or progression in patients with low-risk DCIS
SABCS 2023: Skipping adjuvant radiotherapy may not impact risk of recurrence or progression in patients with low...
SABCS 2023: Some breast cancer survivors may safely de-escalate mammography three years after surgery
SABCS 2023: Some breast cancer survivors may safely de-escalate mammography three years after surgery
ASH 2023: Cell therapy appears safe and effective for lymphoma in remission
ASH 2023: Cell therapy appears safe and effective for lymphoma in remission
ASH 2023: Study provides insight into underlying gene mutations in myelodysplastic syndromes
ASH 2023: Study provides insight into underlying gene mutations in myelodysplastic syndromes
ASH 2023: Pilot study uses circulating tumour DNA to reliably predict relapse in patients with diffuse large B-cell lymphoma
ASH 2023: Pilot study uses circulating tumour DNA to reliably predict relapse in patients with diffuse large B...
ASH 2023: Bispecific antibody drives myeloma precursor condition to undetectable levels in phase II trial
ASH 2023: Bispecific antibody drives myeloma precursor condition to undetectable levels in phase II trial
How drugs can target the thick 'scar tissue' of pancreatic cancer
How drugs can target the thick 'scar tissue' of pancreatic cancer

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation